Tango Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
All right. Good morning, everyone. Thank you all for being here and for those of us who are attending online, nice to have you. My name is Charlie Ferranti. I'm a team member on Chris Shibutani's biopharma research team here at Goldman Sachs. And it's my pleasure to have Barbara Weber, CEO of Tango Therapeutics here with me today. Barbara, good morning.
Good morning, and thank you for having us.
Questions & Answers
Of course. So maybe just to start here, if you could provide an overview of the company, the synthetic lethality platform that you've built on. And it's been an exciting year so far; you've had some clinical data. So maybe just an overview to get us started here.
Yeah. And it's going to get even more exciting over the next 12 months.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
